SPL 1.05% 9.6¢ starpharma holdings limited

Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-81

  1. 3,347 Posts.
    lightbulb Created with Sketch. 792
    I’m afraid you are conveniently missing or ignoring my points. I cannot make them any clearer.

    Starpharma have given away the upside for free. If this program is highly successful in 15 years, then yes the current 22.5 % has potential for significant value. But there is no licence fee and no milestone payments payable to Starpharma.

    Starpharma have taken on the downside risk of failure without any compensation.

    Here’s a maths question for you:
    What is 22.5% of zero?
    Last edited by sarge17: 09/04/24
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.6¢
Change
0.001(1.05%)
Mkt cap ! $39.58M
Open High Low Value Volume
9.6¢ 9.6¢ 9.5¢ $11.41K 118.9K

Buyers (Bids)

No. Vol. Price($)
1 239840 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 65000 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.